● Recruiting

Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

Condition: Chronic Hepatitis B · Sponsor: Ausper Biopharma Co., Ltd.

PhaseN/A

Planned participants200

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.

This description comes directly from the study's public registry record.

Talk to the study team

Lu · 0571-86959519 · clinicaltrial@ausperbio.com

Always discuss trial participation with your own doctor first.

Locations (2)

AusperBio Investigational Site	Guangzhou, Guangdong, China	Recruiting
AusperBio Investigational Site	Changchun, Jilin, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07146100